Related references
Note: Only part of the references are listed.Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1
N. Marques et al.
ONCOGENE (2014)
Zyxin cooperates with PTOV1 to confer retinoic acid resistance by repressing RAR activity
HyeSook Youn et al.
CANCER LETTERS (2013)
miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells
Ai-Yu Gong et al.
BMC CANCER (2012)
Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
Josep Domingo-Domenech et al.
CANCER CELL (2012)
Multifocal Epithelial Tumors and Field Cancerization from Loss of Mesenchymal CSL Signaling
Bing Hu et al.
CELL (2012)
PTOV1 antagonizes MED25 in RAR transcriptional activation
Hye-Sook Youn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
Frederic R. Santer et al.
MOLECULAR CANCER THERAPEUTICS (2011)
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia
Apostolos Klinakis et al.
NATURE (2011)
Structure and VP16 binding of the Mediator Med25 activator interaction domain
Erika Vojnic et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Structure of the VP16 transactivator target in the Mediator
Alexander G. Milbradt et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
PTOV1 is overexpressed in human high-grade malignant tumors
Sara Fernandez et al.
VIRCHOWS ARCHIV (2011)
Notch signalling in solid tumours: a little bit of everything but not all the time
Prathibha Ranganathan et al.
NATURE REVIEWS CANCER (2011)
HDAC6 and Ubp-M BUZ Domains Recognize Specific C-Terminal Sequences of Proteins
Ryan L. Hard et al.
BIOCHEMISTRY (2010)
Genome-wide assessment of differential roles for p300 and CBP in transcription regulation
Yolande F. M. Ramos et al.
NUCLEIC ACIDS RESEARCH (2010)
Notch-1 Signaling Is Lost in Prostate Adenocarcinoma and Promotes PTEN Gene Expression
Jarrett T. Whelan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy
Juan Morote et al.
CLINICAL CANCER RESEARCH (2008)
FGF induces oscillations of Hes1 expression and Ras/ERK activation
Kei Nakayama et al.
CURRENT BIOLOGY (2008)
The Notch pathway in prostate development and cancer
Kevin G. Leong et al.
DIFFERENTIATION (2008)
EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer
Vihren Kolev et al.
NATURE CELL BIOLOGY (2008)
MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation
Hye-Kyung Lee et al.
EMBO JOURNAL (2007)
Ultradian oscillations of Stat, Smad, and Hes1 expression in response to serum
Shigeki Yoshiura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Drosophila split ends homologue SHARP functions as a positive regulator of wnt/β-catenin/T-cell factor signaling in neoplastic transformation
Ying Feng et al.
CANCER RESEARCH (2007)
Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer
V. Fernandez-Majada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation
XD Wang et al.
DEVELOPMENTAL BIOLOGY (2006)
Activation of Notch1 signaling is required for β-catenin-mediated human primary melanoma progression
K Balint et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells
JH van Es et al.
NATURE (2005)
Targeted proteomic analysis of 14-3-3σ, a p53 effector commonly silenced in cancer
A Benzinger et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate
M Kinoshita et al.
INTERNATIONAL JOURNAL OF UROLOGY (2005)
PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts
A Santamaría et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator
FJ Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer
B Comuzzi et al.
JOURNAL OF PATHOLOGY (2004)
Notch1-expressing cells are indispensable for prostatic branching morphogenesis during development and re-growth following castration and androgen replacement
XD Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
JAGGED1 expression is associated with prostate cancer metastasis and recurrence
S Santagata et al.
CANCER RESEARCH (2004)
A novel docking site on Mediator is critical for activation by VP16 in mammalian cells
G Mittler et al.
EMBO JOURNAL (2003)
PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle
A Santamaría et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Notch1 functions as a tumor suppressor in mouse skin
M Nicolas et al.
NATURE GENETICS (2003)
Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal
VI Rebel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
SHARP is a novel component of the Notch/RBP-Jκ signalling pathway
F Oswald et al.
EMBO JOURNAL (2002)
Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation
C Talora et al.
GENES & DEVELOPMENT (2002)
Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins
EC Lai
EMBO REPORTS (2002)
A γ-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish
A Geling et al.
EMBO REPORTS (2002)
Multiclass cancer diagnosis using tumor gene expression signatures
S Ramaswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
HERP, a novel heterodimer partner of HES/E(spl) in notch signaling
T Iso et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Sharp, an inducible cofactor that integrates nuclear receptor repression and activation
YH Shi et al.
GENES & DEVELOPMENT (2001)
PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks
P Benedit et al.
ONCOGENE (2001)
Notch signaling: From the outside in
JS Mumm et al.
DEVELOPMENTAL BIOLOGY (2000)
MAML1, a human homologue of Drosophila Mastermind, is a transcriptional co-activator for NOTCH receptors
LZ Wu et al.
NATURE GENETICS (2000)
SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC to facilitate NotchIC function
SF Zhou et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
A novel proteolytic cleavage involved in Notch signaling:: The role of the disintegrin-metalloprotease TACE
C Brou et al.
MOLECULAR CELL (2000)
The SMRT corepressor is regulated by a MEK-1 kinase pathway: Inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export
SH Hong et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
